trial · primary record
Avelumab
Advanced Bladder Urothelial Carcinoma
| Phase | Phase 3 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 654 |
| Primary completion | 2029-07-15 |
| Primary endpoint | Overall survival (OS) |
| Registry ID | NCT05092958 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:42.626Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05092958
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.